2SPD-013 Economic impact of biosimilar infliximab use

BACKGROUND: The prescriptions of biologics are increasing as new indications and drugs are authorised. Since biosimilar drugs were introduced in the pharmaceutical market, they have become an alternative to continuing with the demand at competitive costs. PURPOSE: To analyse the economic impact from...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Hosp Pharm
Main Authors: García-Fernandez, C, Ruiz-Fuentes, S, Belda-Rustarazo, S, Gómez-Peña, C, Morón-Romero, R, Gómez-Nieto, P
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Group 2018
Fag:
Section 2: Selection, procurement and distribution
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535604/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.34
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker